FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078201891> ?p ?o ?g. }

• W2078201891 endingPage "163" @default.
• W2078201891 startingPage "156" @default.
• W2078201891 abstract "To explore in the daily clinical practice setting that antimuscarinic, Fesoterodine or Solifenacin, provides a greater clinical benefit after changing their prior Overactive Bladder (OAB) therapy with tolterodine extended-release (ER) to other novel antimuscarinic agents.A post-hoc analysis of data from an observational multicenter, cross-sectional, retrospective study. Adult patients of both sexes, with OAB and OAB-V8 score≥8, who switched to fesoterodine or solifenacin within the 3-4 months before study visit from their prior tolterodine-ER-based therapy due to poor response were included. 92 patients were selected for each treatment group, matched (1:1) according to conditioned probability using the propensity score. Benefit of treatment change perceived by the physician and patient was evaluated by means of the Clinical Global Impression of Improvement subscale (CGI-I) and Treatment Benefit Scale (TBS), respectively. Degree of worry, bother and interference with daily living activities due to urinary symptoms, level of satisfaction, and preference for current treatment were also assessed.Fesoterodine provided a significantly greater improvement than solifenacina in terms of therapeutic benefit perceived by the physician according to ICG-I. 96.7% of the patients on fesoterodine treatment vs. 81.6% of the solifenacin group showed a score of improvement in TBS (P<.05). Fesoterodine was also better rated than solifenacin with regard to satisfaction and preference for the new treatment (93.4 vs. 78.2% P<.05).In daily clinical practice the switch from tolterodine LP to fesoterodine seems to provide greater benefits both from the physician's and the patient's point of view compared with those provided by solifenacin." @default.
• W2078201891 created "2016-06-24" @default.
• W2078201891 creator A5013727694 @default.
• W2078201891 creator A5040533518 @default.
• W2078201891 creator A5083786162 @default.
• W2078201891 creator A5087877784 @default.
• W2078201891 creator A5089744658 @default.
• W2078201891 date "2014-04-01" @default.
• W2078201891 modified "2023-09-25" @default.
• W2078201891 title "Beneficio terapéutico tras cambiar tolterodina por otros nuevos antimuscarínicos" @default.
• W2078201891 cites W1267586634 @default.
• W2078201891 cites W1531562711 @default.
• W2078201891 cites W1588537702 @default.
• W2078201891 cites W1834240270 @default.
• W2078201891 cites W1965283949 @default.
• W2078201891 cites W1967308752 @default.
• W2078201891 cites W1967312126 @default.
• W2078201891 cites W1977658266 @default.
• W2078201891 cites W1977661673 @default.
• W2078201891 cites W1979559476 @default.
• W2078201891 cites W1981006688 @default.
• W2078201891 cites W1982223434 @default.
• W2078201891 cites W2009593049 @default.
• W2078201891 cites W2014737244 @default.
• W2078201891 cites W2015661877 @default.
• W2078201891 cites W2020512512 @default.
• W2078201891 cites W2024813481 @default.
• W2078201891 cites W2025896506 @default.
• W2078201891 cites W2031756259 @default.
• W2078201891 cites W2034782018 @default.
• W2078201891 cites W2037084010 @default.
• W2078201891 cites W2043753587 @default.
• W2078201891 cites W2051443038 @default.
• W2078201891 cites W2054263301 @default.
• W2078201891 cites W2055428109 @default.
• W2078201891 cites W2061623077 @default.
• W2078201891 cites W2064365016 @default.
• W2078201891 cites W2069136115 @default.
• W2078201891 cites W2071231390 @default.
• W2078201891 cites W2080534713 @default.
• W2078201891 cites W2081314545 @default.
• W2078201891 cites W2090849097 @default.
• W2078201891 cites W2092473900 @default.
• W2078201891 cites W2133603145 @default.
• W2078201891 cites W2140247818 @default.
• W2078201891 cites W2150291618 @default.
• W2078201891 cites W2152184709 @default.
• W2078201891 cites W2153390278 @default.
• W2078201891 cites W2998401499 @default.
• W2078201891 cites W4765708 @default.
• W2078201891 doi "https://doi.org/10.1016/j.acuro.2013.07.008" @default.
• W2078201891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24119382" @default.
• W2078201891 hasPublicationYear "2014" @default.
• W2078201891 type Work @default.
• W2078201891 sameAs 2078201891 @default.
• W2078201891 citedByCount "2" @default.
• W2078201891 countsByYear W20782018912014 @default.
• W2078201891 countsByYear W20782018912015 @default.
• W2078201891 crossrefType "journal-article" @default.
• W2078201891 hasAuthorship W2078201891A5013727694 @default.
• W2078201891 hasAuthorship W2078201891A5040533518 @default.
• W2078201891 hasAuthorship W2078201891A5083786162 @default.
• W2078201891 hasAuthorship W2078201891A5087877784 @default.
• W2078201891 hasAuthorship W2078201891A5089744658 @default.
• W2078201891 hasConcept C126322002 @default.
• W2078201891 hasConcept C126894567 @default.
• W2078201891 hasConcept C142724271 @default.
• W2078201891 hasConcept C159110408 @default.
• W2078201891 hasConcept C204787440 @default.
• W2078201891 hasConcept C23131810 @default.
• W2078201891 hasConcept C27081682 @default.
• W2078201891 hasConcept C2775944032 @default.
• W2078201891 hasConcept C2776000289 @default.
• W2078201891 hasConcept C2778531004 @default.
• W2078201891 hasConcept C2778941218 @default.
• W2078201891 hasConcept C2779502394 @default.
• W2078201891 hasConcept C2781020410 @default.
• W2078201891 hasConcept C71924100 @default.
• W2078201891 hasConceptScore W2078201891C126322002 @default.
• W2078201891 hasConceptScore W2078201891C126894567 @default.
• W2078201891 hasConceptScore W2078201891C142724271 @default.
• W2078201891 hasConceptScore W2078201891C159110408 @default.
• W2078201891 hasConceptScore W2078201891C204787440 @default.
• W2078201891 hasConceptScore W2078201891C23131810 @default.
• W2078201891 hasConceptScore W2078201891C27081682 @default.
• W2078201891 hasConceptScore W2078201891C2775944032 @default.
• W2078201891 hasConceptScore W2078201891C2776000289 @default.
• W2078201891 hasConceptScore W2078201891C2778531004 @default.
• W2078201891 hasConceptScore W2078201891C2778941218 @default.
• W2078201891 hasConceptScore W2078201891C2779502394 @default.
• W2078201891 hasConceptScore W2078201891C2781020410 @default.
• W2078201891 hasConceptScore W2078201891C71924100 @default.
• W2078201891 hasIssue "3" @default.
• W2078201891 hasLocation W20782018911 @default.
• W2078201891 hasLocation W20782018912 @default.
• W2078201891 hasOpenAccess W2078201891 @default.
• W2078201891 hasPrimaryLocation W20782018911 @default.
• W2078201891 hasRelatedWork W1793611756 @default.

• next